These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment? Muntean AG; Hess JL Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728 [TBL] [Abstract][Full Text] [Related]
6. The efficiency of murine MLL-ENL-driven leukemia initiation changes with age and peaks during neonatal development. Okeyo-Owuor T; Li Y; Patel RM; Yang W; Casey EB; Cluster AS; Porter SN; Bryder D; Magee JA Blood Adv; 2019 Aug; 3(15):2388-2399. PubMed ID: 31405949 [TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities. Horton SJ; Walf-Vorderwülbecke V; Chatters SJ; Sebire NJ; de Boer J; Williams O Blood; 2009 May; 113(20):4922-9. PubMed ID: 19029444 [TBL] [Abstract][Full Text] [Related]
8. Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models. Ono R; Masuya M; Inoue N; Shinmei M; Ishii S; Maegawa Y; Maharjan BD; Katayama N; Nosaka T PLoS One; 2021; 16(3):e0248425. PubMed ID: 33705482 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional activation by MLL fusion proteins in leukemogenesis. Yokoyama A Exp Hematol; 2017 Feb; 46():21-30. PubMed ID: 27865805 [TBL] [Abstract][Full Text] [Related]
10. Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C. Schwieger M; Schüler A; Forster M; Engelmann A; Arnold MA; Delwel R; Valk PJ; Löhler J; Slany RK; Olson EN; Stocking C Blood; 2009 Sep; 114(12):2476-88. PubMed ID: 19584403 [TBL] [Abstract][Full Text] [Related]
11. MLL chimeric protein activation renders cells vulnerable to chromosomal damage: an explanation for the very short latency of infant leukemia. Eguchi M; Eguchi-Ishimae M; Knight D; Kearney L; Slany R; Greaves M Genes Chromosomes Cancer; 2006 Aug; 45(8):754-60. PubMed ID: 16688745 [TBL] [Abstract][Full Text] [Related]
12. Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia. Liu T; Jankovic D; Brault L; Ehret S; Baty F; Stavropoulou V; Rossi V; Biondi A; Schwaller J Leukemia; 2010 Mar; 24(3):601-12. PubMed ID: 20072157 [TBL] [Abstract][Full Text] [Related]
13. Continuous MLL-ENL expression is necessary to establish a "Hox Code" and maintain immortalization of hematopoietic progenitor cells. Horton SJ; Grier DG; McGonigle GJ; Thompson A; Morrow M; De Silva I; Moulding DA; Kioussis D; Lappin TR; Brady HJ; Williams O Cancer Res; 2005 Oct; 65(20):9245-52. PubMed ID: 16230385 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene. Elia L; Grammatico S; Paoloni F; Vignetti M; Rago A; Cenfra N; Mecarocci S; Mancini M; Luciani M; Di Raimondo F; Cazzaniga G; Matarazzo M; Moleti ML; Santoro L; Gaidano G; Foà R; Mandelli F; Cimino G Am J Hematol; 2011 Dec; 86(12):993-7. PubMed ID: 21953510 [TBL] [Abstract][Full Text] [Related]
15. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression. Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771 [TBL] [Abstract][Full Text] [Related]
16. Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation. Ono R; Kumagai H; Nakajima H; Hishiya A; Taki T; Horikawa K; Takatsu K; Satoh T; Hayashi Y; Kitamura T; Nosaka T Leukemia; 2009 Dec; 23(12):2197-209. PubMed ID: 19710696 [TBL] [Abstract][Full Text] [Related]
17. Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19ARF. Nishimoto N; Arai S; Ichikawa M; Nakagawa M; Goyama S; Kumano K; Takahashi T; Kamikubo Y; Imai Y; Kurokawa M Blood; 2011 Sep; 118(9):2541-50. PubMed ID: 21757616 [TBL] [Abstract][Full Text] [Related]
18. Mixed lineage leukemia: roles in human malignancies and potential therapy. Marschalek R FEBS J; 2010 Apr; 277(8):1822-31. PubMed ID: 20236311 [TBL] [Abstract][Full Text] [Related]